Get started
Author

Ethan Tobias

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
2018 · Jonathan T. Lei, Jieya Shao, et al. · Cell Reports · 108
PDF
Evaluation of PARP inhibition as a platinum sparing strategy in Brca2-deficient pancreatic tumors.
2014 · Maeve Aine Lowery, Alycia Lee, et al. · Journal of Clinical Oncology · 8
Rare presentation of multisystem inflammatory syndrome in an adult associated with SARS-CoV-2 infection: unilateral neck swelling
2021 · Mozhu Li, Waqas Haque, et al. · BMJ Case Reports · 7
Safety and tolerability of all-trans-retinoic acid, bevacizumab, and atezolizumab in refractory microsatellite stable colorectal cancer.
2026 · Muhammet Ozer, Nilesh Verma, et al. · Journal of Clinical Oncology · 2
Growth factor use and rate of neutropenic complications in breast cancer patients treated with dose-dense paclitaxel: A 5-year experience from a safety net hospital.
2019 · Racha Halawi, Kavi Patel, et al. · Journal of Clinical Oncology
Abstract 5240: Functional and therapeutic significance of ESR1 gene fusions in breast cancer
2018 · Jonathan T. Lei, Jieya Shao, et al. · Cancer Research
Rates of hepatitis b screening and prophylactic treatment before immunosuppressive therapy in hematological malignancies.
2018 · Ethan Tobias, Bernard Tawfik · Journal of Clinical Oncology
Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer
2018 · JT Lei, J Shao, et al. · Cancer Research
Abstract 1033: Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
2017 · Jonathan T. Lei, Jieya Shao, et al. · Cancer Research
Abstract PD2-03: Recurrent functionally diverse in-frame ESR1 gene fusions drive endocrine resistance in breast cancer
2017 · JT Lei, J Shao, et al. · Cancer Research
Works count: 10
Citation count: 125
H-index: 3
I10-index: 1
Year
Topic
Type